Jie-hong Jiang

Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Shen-Ying Zhang, Q. Gong, Xinxin Zhang, 2008, World journal of gastroenterology.

Role of tissue disorder markers in the evaluation of disease progress and outcome prediction: a prospective cohort study in non‐cardiac critically ill patients

Zi Chen, E. Chen, Jie-hong Jiang, 2010, Journal of clinical laboratory analysis.

Serum WFA+‐M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection

F. Liu, A. Kuno, Q. Gong, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon‐α treatment in HBeAg‐positive chronic hepatitis B patients

Q. Gong, Jiming Zhang, De-min Yu, 2018, Journal of medical virology.

Serum HBeAg sero-conversion correlated with decrease of HBsAg and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine.

Y. Wen, Xinxin Zhang, Youhua Xie, 2010, Vaccine.

Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection

F. Liu, G. Zang, Ming-jie Wang, 2015, Journal of Clinical Microbiology.

MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.

Shen-Ying Zhang, Q. Gong, Yue Han, 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg‐positive chronic hepatitis B naïve patients

Yueqiu Gao, Q. Gong, Jiming Zhang, 2021, Journal of viral hepatitis.